Molecular imaging of tumor angiogenesis using αvβ3-integrin targeted multimodal quantum dots
Open Access
- 9 December 2008
- journal article
- research article
- Published by Springer Nature in Angiogenesis
- Vol. 12 (1) , 17-24
- https://doi.org/10.1007/s10456-008-9124-2
Abstract
Molecular imaging of angiogenesis is urgently needed for diagnostic purposes such as early detection, monitoring of (angiostatic) therapy and individualized therapy. Multimodality molecular imaging is a promising and refined technique to study tumor angiogenesis, which has so far been largely unexplored due to the lack of suitable multimodal contrast agents. Here, we report on the application of a novel αvβ3-specific quantum dot-based nanoparticle, which has been optimized for both optical and magnetic resonance detection of tumor angiogenesis. Upon intravenous injection of RGD-pQDs in tumor-bearing mice, intravital microscopy allowed the detection of angiogenically activated endothelium at cellular resolution with a small scanning window and limited penetration depth, while magnetic resonance imaging was used to visualize angiogenesis at anatomical resolution throughout the entire tumor. Fluorescence imaging allowed whole-body investigation of angiogenic activity. Using these quantum dots and the aforementioned imaging modalities, the angiogenic tumor vasculature was readily detected with the highest angiogenic activity occurring in the periphery of the tumor. This nanoparticle may be employed for multimodality imaging of a variety of diseases that are accompanied by activation of endothelial cells. Furthermore, the current technology might be developed for molecular imaging of other pathophysiological processes.Keywords
This publication has 24 references indexed in Scilit:
- Real-Time Intravital Imaging of RGD−Quantum Dot Binding to Luminal Endothelium in Mouse Tumor NeovasculatureNano Letters, 2008
- Imaging of Vx‐2 rabbit tumors with ανβ3‐integrin‐targeted 111In nanoparticlesInternational Journal of Cancer, 2007
- Earlyin vivoassessment of angiostatic therapy efficacy by molecular MRIThe FASEB Journal, 2007
- MR molecular imaging and fluorescence microscopy for identification of activated tumor endothelium using a bimodal lipidic nanoparticleThe FASEB Journal, 2005
- Quantum dot bioconjugates for imaging, labelling and sensingNature Materials, 2005
- Molecular MR imaging of melanoma angiogenesis with ανβ3‐targeted paramagnetic nanoparticlesMagnetic Resonance in Medicine, 2005
- In vivo cancer targeting and imaging with semiconductor quantum dotsNature Biotechnology, 2004
- The designer antiangiogenic peptide anginex targets tumor endothelial cells and inhibits tumor growth in animal modelsThe FASEB Journal, 2002
- Targeting of RGD‐modified proteins to tumor vasculature: A pharmacokinetic and cellular distribution studyInternational Journal of Cancer, 2002
- Molecular imaging of tumor angiogenesisJournal of Cellular Biochemistry, 2002